Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex - PubMed (original) (raw)
. 2003 Nov;285(5):H1890-9.
doi: 10.1152/ajpheart.00464.2003. Epub 2003 Aug 7.
Affiliations
- PMID: 12907423
- DOI: 10.1152/ajpheart.00464.2003
Free article
Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex
Ken Kazama et al. Am J Physiol Heart Circ Physiol. 2003 Nov.
Free article
Abstract
We investigated whether angiotensin II (ANG II), a peptide that plays a central role in the genesis of hypertension, alters the coupling between synaptic activity and cerebral blood flow (CBF), a critical homeostatic mechanism that assures adequate cerebral perfusion to active brain regions. The somatosensory cortex was activated by stroking the facial whiskers in anesthetized C57BL/6J mice while local CBF was recorded by laser-Doppler flowmetry. Intravenous ANG II infusion (0.25 mug.kg-1.min-1) increased mean arterial pressure (MAP) from 82 +/- 2 to 102 +/- 3 mmHg (P < 0.05) without affecting resting CBF (P > 0.05). ANG II attenuated the CBF increase produced by whisker stimulation by 65% (P < 0.05) but did not affect the response to hypercapnia or to neocortical application of the nitric oxide donor S-nitroso-N-acetyl penicillamine (P > 0.05). The effect of ANG II on functional hyperemia persisted if the elevation in MAP was offset by controlled hemorrhage or prevented by topical application of the peptide to the activated cortex. ANG II did not reduce the amplitude of the P1 wave of the field potentials evoked by whisker stimulation (P > 0.05). Infusion of phenylephrine increased MAP (P > 0.05 from ANG II) but did not alter the functional hyperemic response (P > 0.05). The data suggest that ANG II alters the coupling between CBF and neural activity. The mechanisms of the effect are not related to the elevation in MAP and/or to inhibition of the synaptic activity evoked by whisker stimulation. The imbalance between CBF and neural activity induced by ANG II may alter the homeostasis of the neuronal microenvironment and contribute to brain dysfunction during ANG II-induced hypertension.
Similar articles
- Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals.
Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C. Kazama K, et al. Circ Res. 2004 Nov 12;95(10):1019-26. doi: 10.1161/01.RES.0000148637.85595.c5. Epub 2004 Oct 21. Circ Res. 2004. PMID: 15499027 - The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension.
Capone C, Faraco G, Park L, Cao X, Davisson RL, Iadecola C. Capone C, et al. Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H397-407. doi: 10.1152/ajpheart.00679.2010. Epub 2010 Oct 22. Am J Physiol Heart Circ Physiol. 2011. PMID: 20971763 Free PMC article. - Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II.
Capone C, Faraco G, Anrather J, Zhou P, Iadecola C. Capone C, et al. Hypertension. 2010 Apr;55(4):911-7. doi: 10.1161/HYPERTENSIONAHA.109.145813. Epub 2010 Mar 1. Hypertension. 2010. PMID: 20194308 Free PMC article. - Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex.
Niwa K, Araki E, Morham SG, Ross ME, Iadecola C. Niwa K, et al. J Neurosci. 2000 Jan 15;20(2):763-70. doi: 10.1523/JNEUROSCI.20-02-00763.2000. J Neurosci. 2000. PMID: 10632605 Free PMC article. - The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic.
Girouard H, Lessard A, Capone C, Milner TA, Iadecola C. Girouard H, et al. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H156-63. doi: 10.1152/ajpheart.01137.2007. Epub 2007 Nov 2. Am J Physiol Heart Circ Physiol. 2008. PMID: 17982007
Cited by
- Atherosclerotic burden and cerebral small vessel disease: exploring the link through microvascular aging and cerebral microhemorrhages.
Csiszar A, Ungvari A, Patai R, Gulej R, Yabluchanskiy A, Benyo Z, Kovacs I, Sotonyi P, Kirkpartrick AC, Prodan CI, Liotta EM, Zhang XA, Toth P, Tarantini S, Sorond FA, Ungvari Z. Csiszar A, et al. Geroscience. 2024 Oct;46(5):5103-5132. doi: 10.1007/s11357-024-01139-7. Epub 2024 Apr 19. Geroscience. 2024. PMID: 38639833 Free PMC article. Review. - Treatment of hypertension and obstructive sleep apnea counteracts cognitive decline in common neurocognitive disorders in diagnosis-related patterns.
Kujovic M, Lipka T, Zalman M, Baumann L, Jänner M, Baumann B. Kujovic M, et al. Sci Rep. 2023 May 9;13(1):7556. doi: 10.1038/s41598-023-33701-2. Sci Rep. 2023. PMID: 37160982 Free PMC article. - Cardiometabolic health, menopausal estrogen therapy and the brain: How effects of estrogens diverge in healthy and unhealthy preclinical models of aging.
Daniel JM, Lindsey SH, Mostany R, Schrader LA, Zsombok A. Daniel JM, et al. Front Neuroendocrinol. 2023 Jul;70:101068. doi: 10.1016/j.yfrne.2023.101068. Epub 2023 Apr 13. Front Neuroendocrinol. 2023. PMID: 37061205 Free PMC article. Review. - Hypertension, Neurovascular Dysfunction, and Cognitive Impairment.
Santisteban MM, Iadecola C, Carnevale D. Santisteban MM, et al. Hypertension. 2023 Jan;80(1):22-34. doi: 10.1161/HYPERTENSIONAHA.122.18085. Epub 2022 Sep 21. Hypertension. 2023. PMID: 36129176 Free PMC article. Review. - Angiotensin II Disrupts Neurovascular Coupling by Potentiating Calcium Increases in Astrocytic Endfeet.
Boily M, Li L, Vallerand D, Girouard H. Boily M, et al. J Am Heart Assoc. 2021 Sep 7;10(17):e020608. doi: 10.1161/JAHA.120.020608. Epub 2021 Aug 28. J Am Heart Assoc. 2021. PMID: 34459216 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous